UltraSound - Technology Information PortalMonday, 25 March 2019
Info
  Sheets



Out-
      side
 




 
 'Bristol-Myers Squibb Medical Imaging, Inc' 
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
Result : Searchterm 'Bristol-Myers Squibb Medical Imaging, Inc' found in 1 term [] and 2 definitions [])
1 - 3 (of 3)     
Result Pages : [1]
US Resources  
Societies - Renal - Probes Transducers - Liver - 3d UltraSound - Movies
 
Bristol-Myers Squibb Medical Imaging, Inc.MRI Resource Directory:<br> - Manufacturers -
 
www.bmsmi.com

'Bristol-Myers Squibb Medical Imaging is a worldwide leader in cardiovascular imaging whose mission is to extend and enhance human life by offering innovative approaches to see deeper into the heart and vasculature. Bristol-Myers Squibb Medical Imaging, Inc. is a wholly-owned subsidiary of Bristol-Myers Squibb Company (NYSE: BMY), a pharmaceutical and related health care products company.'

Ultrasound Related Product Lines:
Contrast Agents:
TRADE NAME FOR SALE FOR SALE /
DEVELOPMENT
DEVELOPMENT
Definity®

Contact Information:
MAIL Bristol-Myers Squibb Medical Imaging
Bldg. 200-2
331 Treble Cove Rd.
N. Billerica, MA 01862
USA
PHONE +1-800-299-3431
FAX +1-978-436-7501
E-MAIL mics@bms.com
ONLINE www.radiopharm.com/
spacer

• View the news results for 'Bristol-Myers Squibb Medical Imaging, Inc.' (1).


• Related Searches:
    • Power Mode
    • Breast Ultrasound
    • Transvaginal Sonography
    • Attenuation Coefficient
    • Reverberation Artifact

 Further Reading:
  Basics:
Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical ImagingOpen this link in a new window
Tuesday, 8 January 2008   by www.prnewswire.com    
US Resources  
Portable UltraSound - Services and Supplies - Musculoskeletal and Joint - Ultrasound Guided Interventions - Software - Probes Transducers
 
Definity®InfoSheet: - Contrast Agents - 
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:<br> - Contrast Agents -
 
www.definityimaging.com/newsroom/newsroom/factsheet.asp

From Bristol-Myers Squibb Medical Imaging Inc.
Activated DEFINITY® Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. The perflutren lipid microspheres exhibit lower acoustic impedance than blood and enhance the intrinsic backscatter of blood.
Echocardiography with Definity produced more detailed images of the heart in difficult-to-image patients versus echocardiography alone, and images obtained with the contrast agent provided a more accurate assessment of segmental wall motion compared with unenhanced images.
See also Coherent Contrast Imaging.

In August 2001 DuPont Pharmaceuticals Company received FDA approval.

Drug Information and Specification:
RESEARCH NAME DMP 115, MRX 115
DEVELOPER Bristol-Myers Squibb Medical Imaging, Inc.
INDICATION -
DEVELOPMENT STAGE
LV, echocardiography
for sale
APPLICATION Intravenous
TYPE Microbubbles
SHELL Lipids:DPPA, DPPC, MPEG5000 DPPE
CHARGE Negative
GAS Octafluoropropane
MICROBUBBLE SIZE 98% < 10µm
PRESENTATION Package contains four 2mL clear glass single-use vials.
STORAGE Refrigerate 2–8°C
PREPARATION Activate through Vialmix agitation
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!

Distribution Information:
TERRITORY DISTRIBUTOR
USA, EU Bristol-Myers Squibb Medical Imaging, Inc.

spacer

 Further Reading:
  Basics:
Definity Product DescriptionOpen this link in a new window
  News & More:
CONTRAST ECHOCARDIOGRAPHY: NEW AGENTSOpen this link in a new window
   by eurheartj.oxfordjournals.org    
molecular imaging using ultrasoundOpen this link in a new window
   by bjr.birjournals.org    
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in EchocardiographyOpen this link in a new window
November 2008   by www.asecho.org    
US Resources  
Jobs - Image Quality - Doppler UltraSound - Thyroid - 3d UltraSound - Pediatric
 
Imagent®InfoSheet: - Contrast Agents - 
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:<br> - Contrast Agents -
 
Imagent® is an injectable suspension for intravenous administration during a sonogram. This diagnostic contrast agent for enhancement of ultrasound images contains perflexane lipid microspheres. Imagent® US is indicated in the assessment of heart function and perfusion, as well as the detection of tumors and blood flow abnormalities by using gray scale, color Doppler, and harmonic ultrasound imaging techniques.
During the course of its development, the brand name for this product has changed from Imagent to Imavist (between August 2000 and March 2002) back to Imagent. The manufacturer's 06/03/02 press release announcing FDA approval refers to the product as "Imagent (formerly Imavist)," and the approval notice and monograph posted at the FDA site refers to the product as Imagent.
Jointly developed by Alliance Pharmaceutical Corporation and Schering AG (Germany). Source: PR Newswire - 10/10/96, 03/31/98, 10/13/99, 03/13/01, 10/08/01; FDA approvals - 05/31/02; Alliance Pharmaceutical press release - 06/03/02.

Drug Information and Specification:
RESEARCH NAME AF0150
DEVELOPER IMCOR Pharmaceuticals, Inc.
INDICATION -
DEVELOPMENT STAGE
Echocardiography
APPLICATION Intravenous
TYPE Microbubbles
SHELL Lipid: DMPC
CHARGE Neutral
GAS Perfluorohexane/Nitrogen
MICROBUBBLE SIZE 99.8% < 10µm
PRESENTATION -
STORAGE Room Temp 15–30°C
PREPARATION Reconstitute with 10 ml water
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!

Distribution Information:
TERRITORY DISTRIBUTOR
USA, EU Bristol-Myers Squibb Medical Imaging, Inc.

spacer

 Further Reading:
  Basics:
CONTRAST ECHOCARDIOGRAPHY: NEW AGENTSOpen this link in a new window
   by eurheartj.oxfordjournals.org    
  News & More:
The role of ultrasound in molecular imaging(.pdf)Open this link in a new window
2003   by bjr.birjournals.org    
IMCOR Pharmaceutical Co., Alliance Pharmaceutical Corp., Molecular Biosystems, Inc. and GE Healthcare Ltd., Inc. Enter Into Cross-Licensing Agreement for Ultrasound Contrast PatentsOpen this link in a new window
   by www.prnewswire.com    
US Resources  
Heart - RIS - Portable UltraSound - Education - Non-English - Fetal
 
Related Searches:
 • Non-Linear Scattering
 • Receiver
 • Clutter
 • Alliance Pharmaceutical Corp.
 • FFsonic UF-5800A
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
     1 - 3 (of 3)     
Result Pages : [1]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

US-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  


Look
      Ups



UltraSound - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2006 - 2018 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2015-03-04 09:17:02]